General MedicationsINTRAVENOUSStandard
SODIUM NITRITE
SODIUM NITRITE
Standard Dose
300MG/10ML (30MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM NITRITE is listed in Drugs@FDA under application 203922 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM NITRITE Form and strength SOLUTION;INTRAVENOUS - 300MG/10ML (30MG/ML) Sponsor HOPE PHARMS Submission history Latest submission status date: 2021-01-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM NITRITE is listed in Drugs@FDA under application 203922 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM NITRITE Form and strength SOLUTION;INTRAVENOUS - 300MG/10ML (30MG/ML) Sponsor HOPE PHARMS Submission history Latest submission status date: 2021-01-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.